Cite
HARVARD Citation
Glintborg, B. et al. (n.d.). THU0189 One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2, 061 patients with inflammatory arthritis followed in the danbio registry. Annals of the rheumatic diseases. pp. 313-314. [Online].